TapewireFind a company

person · Reporting owner

HILZINGER KURT J

Disclosed activity across 2 companies

Tapewire entity
33645
SEC CIK
0001191504

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
HUMANA INCHUM · Entity 1429DirectorSeptember 30, 2026October 02, 2026
Outlook Therapeutics, Inc.OTLK · Entity 608DirectorMay 26, 2026May 27, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

HUMANA INC

Report date September 30, 2026 · Filed October 02, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect16,772 Reported balance After 2026-09-30 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2026-09-30 · Grant · Acquired 238 · Balance 16,772

F3: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect24,800 Reported balance Holding disclosure · report date 2026-09-30 · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · Balance 24,800

F1: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect3,364 Reported balance Holding disclosure · report date 2026-09-30 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance 3,364

F2: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Humana CommonSEC Table I · non-derivativeDirect19,448 Reported balance Holding disclosure · report date 2026-09-30 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 19,448

Filing footnotes · ownership attribution and instrument terms

F1: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F2: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Outlook Therapeutics, Inc.

Report date May 26, 2026 · Filed May 27, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect423,655 Reported balance After 2026-05-26 transaction · row 1
1 source row

Row 1 · 2026-05-26 · Purchase · Acquired 400,000 · Balance 423,655

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
December 26, 2018 Filed Dec 28, 2018 22:06 UTC Outlook Therapeutics, Inc. OTLK · Entity 608 PurchaseCommon Stock 5,714 $0.54 $3,085.56
Disclosure

SEC source: 0001209191-18-064336 · doc4.xml · nonDerivative · entry 1

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,227

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4759 - $0.5950, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
December 24, 2018 Filed Dec 26, 2018 22:17 UTC Outlook Therapeutics, Inc. OTLK · Entity 608 PurchaseCommon Stock 1,113 $0.66 $734.58
Disclosure

SEC source: 0001209191-18-064123 · doc4.xml · nonDerivative · entry 2

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,513

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.65 - $0.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
December 21, 2018 Filed Dec 26, 2018 22:17 UTC Outlook Therapeutics, Inc. OTLK · Entity 608 PurchaseCommon Stock 3,600 $0.65 $2,340.00
Disclosure

SEC source: 0001209191-18-064123 · doc4.xml · nonDerivative · entry 1

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,400

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.63 - $0.6706, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes an aggregate of 7,246 shares that were issued upon vesting and settlement of Restricted Stock Units previously reported in a Form 3 filed with the Securities and Exchange Commission on May 12, 2016 but erroneously omitted from Column 5 in subsequent filings.

Read SEC document
November 09, 2018 Filed Nov 13, 2018 21:56 UTC Outlook Therapeutics, Inc. ONS · Entity 608 GrantStock Option (Right to Buy) · Derivative 203,851 $0.61 Strike: $0.89 $124,960.66
Disclosure

SEC source: 0001209191-18-058304 · doc4.xml · derivative · entry 1

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,851

Underlying: Common Stock · 203,851 shares

Expires 2028-11-09

F2 · price: This option was issued to the Reporting Person pursuant to the Issuer's 2015 Equity Incentive Plan in lieu of two years of cash retainer and meeting fees of $125,000.

F1 · derivative.exercise_date: Immediately exercisable.

Read SEC document
September 28, 2018 Filed Oct 2, 2018 15:22 UTC HUMANA INC HUM · Entity 1429 GrantStock Unit · Derivative 254 $336.65 $85,509.10
Disclosure

SEC source: 0000049071-18-000119 · edgar.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,059

Underlying: Humana Common · 254 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
September 21, 2018 Filed Sep 25, 2018 20:59 UTC Outlook Therapeutics, Inc. ONS · Entity 608 GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $0.92 $0.00
Disclosure

SEC source: 0001209191-18-052158 · doc4.xml · derivative · entry 1

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-09-21

F1 · derivative.exercise_date: 100% of the shares underlying the option shall vest on September 21, 2019, subject to the Reporting Person providing continuous service to the Issuer on such date.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 15:08 UTC HUMANA INC HUM · Entity 1429 GrantStock Unit · Derivative 280 $299.02 $83,725.60
Disclosure

SEC source: 0000049071-18-000095 · edgar.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,805

Underlying: Humana Common · 280 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
March 29, 2018 Filed Apr 3, 2018 16:16 UTC HUMANA INC HUM · Entity 1429 GrantStock Unit · Derivative 311 $267.24 $83,111.64
Disclosure

SEC source: 0000049071-18-000059 · edgar.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,525

Underlying: Humana Common · 311 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
January 02, 2018 Filed Jan 3, 2018 20:57 UTC HUMANA INC HUM · Entity 1429 GrantRestricted Stock Units · Derivative 658 $0.00 $0.00
Disclosure

SEC source: 0000049071-18-000004 · edgar.xml · derivative · entry 5

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 658

Underlying: Humana Common · 658 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

Read SEC document
December 31, 2017 Filed Jan 3, 2018 20:57 UTC HUMANA INC HUM · Entity 1429 GrantStock Unit · Derivative 346 $249.45 $86,309.70
Disclosure

SEC source: 0000049071-18-000004 · edgar.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,214

Underlying: Humana Common · 346 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2017 Filed Jan 3, 2018 20:57 UTC HUMANA INC HUM · Entity 1429 GrantStock Unit · Derivative 173 $249.45 $43,154.85
Disclosure

SEC source: 0000049071-18-000004 · edgar.xml · derivative · entry 3

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 862

Underlying: Humana Common · 173 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
October 26, 2017 Filed Oct 30, 2017 22:07 UTC Outlook Therapeutics, Inc. ONS · Entity 608 GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001209191-17-058366 · doc4.xml · derivative · entry 1

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-10-26

F1 · derivative.exercise_date: 100% of the shares underlying the option shall vest on October 26, 2018, subject to the Reporting Person providing continuous service to the Issuer on such date.

Read SEC document
September 29, 2017 Filed Oct 3, 2017 17:34 UTC HUMANA INC HUM · Entity 1429 GrantStock Unit · Derivative 355 $242.26 $86,000.53
Disclosure

SEC source: 0000049071-17-000166 · edgar.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,868

Underlying: Humana Common · 355 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
June 30, 2017 Filed Jul 5, 2017 16:57 UTC HUMANA INC HUM · Entity 1429 GrantStock Unit · Derivative 318 $240.77 $76,564.86
Disclosure

SEC source: 0000049071-17-000138 · edgar.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,513

Underlying: Humana Common · 318 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
March 31, 2017 Filed Apr 4, 2017 20:21 UTC HUMANA INC HUM · Entity 1429 GrantStock Unit · Derivative 371 $206.42 $76,581.82
Disclosure

SEC source: 0000049071-17-000092 · edgar.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,195

Underlying: Humana Common · 371 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
January 23, 2017 Filed Jan 24, 2017 22:44 UTC Outlook Therapeutics, Inc. ONS · Entity 608 OtherWarrant (Right to Buy) · Derivative 12,036 $0.00 Strike: $0.01 $0.00
Disclosure

SEC source: 0001209191-17-005333 · doc4.xml · derivative · entry 2

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,036 shares

Expires 2019-11-08

F1 · kind: Represents the exercise of (i) a Warrant to purchase 7,561 received from Proximare Lifesciences Fund LLC, of which the reporting person is a member, and (ii) a Warrant to purchase 4,475 received from Proximare Lifesciences Fund 2 LLC, of which the reporting person is a member.

F2 · derivative.exercise_date: Immediately exercisable.

Read SEC document
January 23, 2017 Filed Jan 24, 2017 22:44 UTC Outlook Therapeutics, Inc. ONS · Entity 608 OtherCommon Stock 12,036 $0.01 $120.36
Disclosure

SEC source: 0001209191-17-005333 · doc4.xml · nonDerivative · entry 1

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,554

F1 · kind: Represents the exercise of (i) a Warrant to purchase 7,561 received from Proximare Lifesciences Fund LLC, of which the reporting person is a member, and (ii) a Warrant to purchase 4,475 received from Proximare Lifesciences Fund 2 LLC, of which the reporting person is a member.

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:38 UTC HUMANA INC HUM · Entity 1429 GrantRestricted Stock Units · Derivative 761 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000006 · edgar.xml · derivative · entry 5

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 761

Underlying: Humana Common · 761 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

Read SEC document
December 31, 2016 Filed Jan 4, 2017 21:38 UTC HUMANA INC HUM · Entity 1429 GrantStock Unit · Derivative 376 $203.53 $76,527.28
Disclosure

SEC source: 0000049071-17-000006 · edgar.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,824

Underlying: Humana Common · 376 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2016 Filed Jan 4, 2017 21:38 UTC HUMANA INC HUM · Entity 1429 GrantStock Unit · Derivative 144 $203.53 $29,308.32
Disclosure

SEC source: 0000049071-17-000006 · edgar.xml · derivative · entry 3

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 689

Underlying: Humana Common · 144 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
November 30, 2016 Filed Nov 30, 2016 22:25 UTC Outlook Therapeutics, Inc. ONS · Entity 608 OtherCommon Stock 6,885 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-152513 · doc4.xml · nonDerivative · entry 2

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,518

F2 · kind: Represents the receipt of 6,885 shares of Common Stock in a pro rata distribution for no consideration from Proximare Lifesciences Fund 2 LLC, of which the reporting person is a member.

F2 · shares: Represents the receipt of 6,885 shares of Common Stock in a pro rata distribution for no consideration from Proximare Lifesciences Fund 2 LLC, of which the reporting person is a member.

F2 · price: Represents the receipt of 6,885 shares of Common Stock in a pro rata distribution for no consideration from Proximare Lifesciences Fund 2 LLC, of which the reporting person is a member.

Read SEC document
November 28, 2016 Filed Nov 30, 2016 22:25 UTC Outlook Therapeutics, Inc. ONS · Entity 608 OtherWarrant (Right to Buy) · Derivative 12,036 $0.00 Strike: $0.01 $0.00
Disclosure

SEC source: 0001209191-16-152513 · doc4.xml · derivative · entry 3

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,036

Underlying: Common Stock · 12,036 shares

Expires 2019-11-08

F3 · kind: Represents the receipt of (i) a Warrant to purchase 7,561 from Proximare Lifesciences Fund LLC, of which the reporting person is a member, and (ii) a Warrant to purchase 4,475 from Proximare Lifesciences Fund 2 LLC, of which the reporting person is a member, in a pro rata distribution for no consideration.

F3 · shares: Represents the receipt of (i) a Warrant to purchase 7,561 from Proximare Lifesciences Fund LLC, of which the reporting person is a member, and (ii) a Warrant to purchase 4,475 from Proximare Lifesciences Fund 2 LLC, of which the reporting person is a member, in a pro rata distribution for no consideration.

F4 · derivative.exercise_date: Immediately exercisable.

F3 · derivative.underlying_shares: Represents the receipt of (i) a Warrant to purchase 7,561 from Proximare Lifesciences Fund LLC, of which the reporting person is a member, and (ii) a Warrant to purchase 4,475 from Proximare Lifesciences Fund 2 LLC, of which the reporting person is a member, in a pro rata distribution for no consideration.

F3 · balance_after: Represents the receipt of (i) a Warrant to purchase 7,561 from Proximare Lifesciences Fund LLC, of which the reporting person is a member, and (ii) a Warrant to purchase 4,475 from Proximare Lifesciences Fund 2 LLC, of which the reporting person is a member, in a pro rata distribution for no consideration.

Read SEC document
November 28, 2016 Filed Nov 30, 2016 22:25 UTC Outlook Therapeutics, Inc. ONS · Entity 608 OtherCommon Stock 11,633 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-152513 · doc4.xml · nonDerivative · entry 1

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,633

F1 · kind: Represents the receipt of 11,633 shares of Common Stock in a pro rata distribution for no consideration from Proximare Lifesciences Fund LLC, of which the reporting person is a member.

F1 · shares: Represents the receipt of 11,633 shares of Common Stock in a pro rata distribution for no consideration from Proximare Lifesciences Fund LLC, of which the reporting person is a member.

F1 · price: Represents the receipt of 11,633 shares of Common Stock in a pro rata distribution for no consideration from Proximare Lifesciences Fund LLC, of which the reporting person is a member.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 19:37 UTC HUMANA INC HUM · Entity 1429 GrantStock Unit · Derivative 432 $176.54 $76,265.28
Disclosure

SEC source: 0000049071-16-000174 · edgar.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,448

Underlying: Humana Common · 432 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.